Published in Br J Pharmacol on October 01, 1986
Reversal of the cardiotonic and action-potential prolonging effects of DPI 201-106 by BDF 8784, a methyl-indol derivative. Br J Pharmacol (1989) 0.81
Inhibition of the sodium pump by cardioactive DPI 201-106. Br J Pharmacol (1987) 0.75
Characterization of the inotropic and arrhythmogenic action of the sodium channel activator BDF 9148: a comparison to its S-enantiomer BDF 9196, to its congener DPI 201-106, to norepinephrine, and to ouabain. Basic Res Cardiol (1994) 0.75
Classification of antidysrhythmic drugs. Pharmacol Ther B (1975) 1.73
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Modification of single cardiac Na+ channels by DPI 201-106. J Membr Biol (1986) 1.31
The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol (1985) 1.25
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol (1984) 1.04
The depolarizing action of 5-HT on mammalian non-myelinated nerve fibres. Eur J Pharmacol (1978) 0.99
Drugs with a class III antiarrhythmic action. Pharmacol Ther (1982) 0.94
Local anesthetics: effect of pH on activity. Science (1968) 0.91
Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J (1979) 0.89
How increased sodium influx enhances digoxin-induced arrhythmias in guinea-pig atrial muscle. Eur J Pharmacol (1983) 0.88
Methods for the detection and assessment of antiarrhythmic activity. Pharmacol Ther (1984) 0.87
Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors. J Cardiovasc Pharmacol (1985) 0.87
Myocardial concentration of norepinephrine and cyclic AMP in ventricular fibrillation during acute myocardial ischemia. J Cardiovasc Pharmacol (1983) 0.86
Digitalis. Pharmacol Ther (1982) 0.81
The mode of antiarrhythmic action of melperone. Acta Pharmacol Toxicol (Copenh) (1982) 0.81
Action of prilocaine on the vagus nerve and on adrenaline induced extrasystole in dogs. Arch Int Pharmacodyn Ther (1967) 0.79
Pharmacological actions of the antihypertensive agent N-amidino-2-(2,6-dichlorophenyl)acetamide hydrochloride (BS 100-141). Arzneimittelforschung (1975) 2.72
Blood concentrations in man of fluorinated hydrocarbons after inhalation of pressurised aerosols. Lancet (1970) 2.48
Pharmacology of BS 100-141, a centrally acting antihypertensive drug. Clin Exp Pharmacol Physiol (1975) 1.86
The accumulation of 111In-eosinophils induced by inflammatory mediators, in vivo. Immunology (1991) 1.55
Alveolar gas concentrations of fluorocarbons-11 and-12 in man after use of pressurized aerosols. Thorax (1974) 1.52
DPI 201-106, a novel cardioactive agent. Combination of cAMP-independent positive inotropic, negative chronotropic, action potential prolonging and coronary dilatory properties. Naunyn Schmiedebergs Arch Pharmacol (1985) 1.50
Trial of combination of guanethidine and oxprenolol in hypertension. Br Med J (1976) 1.44
Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung (1977) 1.41
Effects of clonidine and BS 100-141 on the EEG sleep pattern in rats. Eur J Pharmacol (1975) 1.36
Global epidemic of human T-cell lymphotropic virus type-I (HTLV-I). J Emerg Med (2000) 1.32
Clinical significance of esterases in man. Clin Pharmacokinet (1985) 1.28
The role of sodium channels in the effects of the cardiotonic compound DPI 201-106 on contractility and membrane potentials in isolated mammalian heart preparations. Eur J Pharmacol (1985) 1.25
The use of anti-tumour necrosis factor therapy in HIV-positive individuals with rheumatic disease. Ann Rheum Dis (2007) 1.23
Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8. J Clin Invest (1995) 1.23
The effect of chemical fixatives on cell walls of Bacillus subtilis. Can J Microbiol (1978) 1.22
PN 200-110, a new calcium antagonist: electrophysiological, inotropic, and chronotropic effects on guinea pig myocardial tissue and effects on contraction and calcium uptake of rabbit aorta. J Cardiovasc Pharmacol (1984) 1.19
Effective measurement of knee alignment using AP knee radiographs. Knee (2008) 1.19
Longevity record for deep-sea invertebrate. Nature (2000) 1.16
Bovine dilated cardiomyopathy: proteomic analysis of an animal model of human dilated cardiomyopathy. Electrophoresis (1999) 1.12
Structure, function and pharmacology of voltage-gated sodium channels. Naunyn Schmiedebergs Arch Pharmacol (2000) 1.12
Effects of the new calcium antagonist PN 200-110 on the myocardium and the regional peripheral circulation in anesthetized cats and dogs. J Cardiovasc Pharmacol (1984) 1.11
Evidence for inhibition by ICS 205-930 and stimulation by BRL 34915 of K+ conductance in cardiac muscle. Naunyn Schmiedebergs Arch Pharmacol (1987) 1.11
Percutaneous penetration and dermal metabolism of triclosan (2,4, 4'-trichloro-2'-hydroxydiphenyl ether). Food Chem Toxicol (2000) 1.11
Human brain, cerebrospinal fluid, and plasma concentrations of diphenylhydantoin and phenobarbital. Clin Pharmacol Ther (1974) 1.09
Substituted phenylacetylguanidines: a new class of antihypertensive agents. Arzneimittelforschung (1975) 1.07
Use of 18F labelled fluorocarbon-11 to investigate the fate of inhaled fluorocarbons in man and in the rat. Thorax (1974) 1.05
Age and the metabolism of drugs. Q J Med (1987) 1.05
An investigation into the characteristics of reperfusion-induced arrhythmias in the anaesthetized rat and their susceptibility to antiarrhythmic agents. Br J Pharmacol (1984) 1.04
In vitro predictions of skin absorption of caffeine, testosterone, and benzoic acid: a multi-centre comparison study. Regul Toxicol Pharmacol (2004) 1.04
Treatment of a case of lanatoside C intoxication with digoxin-specific F(ab')2 antibody fragments. Am Heart J (1979) 1.00
Evidence for different receptor sites for the novel cardiotonic S-DPI 201-106, ATX II and veratridine on the cardiac sodium channel. Eur J Pharmacol (1986) 0.98
A model of cell growth dynamics. J Theor Biol (1967) 0.98
Determination of barbiturates and their metabolites in small plasma samples by gas chromatography-mass spectrometry. Amylorbarbitone and 3'-hydroxyamylobarbitone. J Chromatogr (1973) 0.96
The pyrethroids permethrin and cyhalothrin are potent inhibitors of the mitochondrial complex I. J Pharmacol Exp Ther (1997) 0.96
Aspirin metabolism and efficacy in postoperative dental pain. Br J Clin Pharmacol (1984) 0.96
The metabolism of sympathomimetic bronchodilator drugs by the isolated perfused dog lung. Xenobiotica (1973) 0.95
The effect of alcoholic cirrhosis on the activities of microsomal aldrin epoxidase, 7-ethoxycoumarin O-de-ethylase and epoxide hydrolase, and on the concentrations of reduced glutathione in human liver. Br J Clin Pharmacol (1983) 0.94
Effects of the calcium antagonist PY 108-068 on myocardial tissues in vitro and on reflex tachycardia in vivo. J Cardiovasc Pharmacol (1983) 0.94
Peripheral cholinesterase inhibition by occupational chlorpyrifos exposure in Australian termiticide applicators. Toxicology (2001) 0.94
The effect of alcoholic cirrhosis on the two kinetic components (high and low affinity) of the microsomal 0-deethylation of 7-ethoxycoumarin in human liver. Eur J Clin Pharmacol (1984) 0.94
Inhibitory effects of clonidine and BS 100-141 on responses to sympathetic nerve stimulation in cats and rabbits. Br J Pharmacol (1975) 0.93
The influence of the route of administration on urinary metabolites of isoetharine. Xenobiotica (1974) 0.92
Digitoxin intoxication with severe thrombocytopenia: reversal by digoxin-specific antibodies. Eur J Clin Invest (1983) 0.92
Role of CD18 in the accumulation of eosinophils and neutrophils and local oedema formation in inflammatory reactions in guinea-pig skin. Br J Pharmacol (1994) 0.92
Effects of the new class III antiarrhythmic drug E-4031 on myocardial contractility and electrophysiological parameters. J Cardiovasc Pharmacol (1991) 0.91
Activity of esterases in plasma from Ghanaian and British subjects. Eur J Clin Pharmacol (1986) 0.90
Cardiovascular actions of bromocriptine. Acta Endocrinol Suppl (Copenh) (1978) 0.89
Antiarrhythmic and electrophysiological effects of ICS 205-930, an antagonist of 5-hydroxytryptamine at peripheral receptors. J Cardiovasc Pharmacol (1985) 0.87
Biomechanical performance of powder-free examination gloves. J Emerg Med (1999) 0.87
Identification of a cardiac sodium channel insensitive to synthetic modulators. J Cardiovasc Pharmacol Ther (2001) 0.86
Comparative efficacy of soluble aspirin and aspirin tablets in postoperative dental pain. Eur J Clin Pharmacol (1986) 0.86
5-Hydroxytryptamine mediated contractions in isolated preparations of equine ileum and pelvic flexure: pharmacological characterization of a new 5-HT(4) agonist. J Vet Pharmacol Ther (2002) 0.86
Inter- and intralaboratory variation of in vitro diffusion cell measurements: an international multicenter study using quasi-standardized methods and materials. J Pharm Sci (2005) 0.86
Coma in thrombotic thrombocytopenic purpura. J Neurol Neurosurg Psychiatry (1999) 0.85
Pharmacology of guanfacine. Br J Clin Pharmacol (1980) 0.85
A comparative study of the cardiovascular reactivity in various hypertensive and in normotensive rats. Arzneimittelforschung (1971) 0.85
The distribution of methadone in man. J Pharm Pharmacol (1971) 0.85
Proceedings: Inhibition of effects of accelerator nerve stimulation in cats and rabbits by BS 100-141 and guanabenz. Naunyn Schmiedebergs Arch Pharmacol (1974) 0.85
Pharmacological actions of APP 201-533, a novel cardiotonic agent. J Cardiovasc Pharmacol (1985) 0.84
Ambient, biological, and biological effect monitoring of exposure to polycyclic aromatic hydrocarbons (PAHs). Toxicol Lett (1995) 0.84
2,5-Diphenyloxazole as a probe for microsomal mono-oxygenation in human and rat liver. Xenobiotica (1985) 0.84
A comparative study of the effects of aspirin and paracetamol (acetaminophen) on platelet aggregation and bleeding time. Eur J Clin Pharmacol (1984) 0.84
The effects of cadmium and zinc interactions on the accumulation and tissue distribution of zinc and cadmium in lettuce and spinach. Environ Pollut (1993) 0.84
Generating and influencing Torsades de Pointes--like polymorphic ventricular tachycardia in isolated guinea pig hearts. Basic Res Cardiol (1998) 0.84
The role of metabolism in determining susceptibility to parathion toxicity in man. Toxicol Lett (1999) 0.83
Pertussis toxin treatment does not inhibit the effects of the potassium channel opener BRL 34915 on rat isolated vascular and cardiac tissues. Naunyn Schmiedebergs Arch Pharmacol (1988) 0.83
Mutations in the reduced-folate carrier affect protein localization and stability. Biochem J (2000) 0.83
The effect of age on pathways of drug metabolism in human liver. Age Ageing (1984) 0.83
Effects of nitrogen oxides on natural killer cells in glass craftsmen and braziers. Occup Environ Med (1996) 0.82
Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration. Toxicol Appl Pharmacol (2004) 0.82
Integrity of powder-free examination gloves to bacteriophage penetration. J Biomed Mater Res (1999) 0.82
The efficacy of benorylate in postoperative dental pain. Eur J Clin Pharmacol (1989) 0.82
Whole body heat stress fails to limit infarct size in the reperfused rabbit heart. Cardiovasc Res (1992) 0.82
Percutaneous penetration of 2-phenoxyethanol through rat and human skin. Food Chem Toxicol (1998) 0.82
Nature and role of xenobiotic metabolizing esterases in rat liver, lung, skin and blood. Biochem Pharmacol (1993) 0.82
Cardiovascular actions of DPI 201-106, a novel cardiotonic agent. J Cardiovasc Pharmacol (1986) 0.81
The effect of sulphur mustard on glutathione levels in rat lung slices and the influence of treatment with arylthiols and cysteine esters. Hum Exp Toxicol (1996) 0.81
Interindividual variations in enzymes controlling organophosphate toxicity in man. Hum Exp Toxicol (1992) 0.81
Concentration of volatile fatty acids in digesta samples obtained from healthy cows and cows with cecal dilatation or dislocation. Am J Vet Res (1999) 0.81
Aldrin epoxidation kinetics in small samples of human liver. Biochem Pharmacol (1982) 0.81
Human xenobiotic metabolizing esterases in liver and blood. Biochem Pharmacol (1993) 0.81
Structural organization of the reduced folate carrier gene in Chinese hamster ovary cells. J Biol Chem (1996) 0.81
Role of nitric oxide in the dilator actions of capsaicin-sensitive nerves in the rabbit coronary circulation. Neuropeptides (1997) 0.80
The prevention and reversal of digoxin intoxication with specific antibodies. Am Heart J (1978) 0.80
Biomechanical performance of examination gloves. J Biomed Mater Res (1999) 0.80
Pharmacodynamics and pharmacokinetics of single doses of ketanserin and propranolol alone and in combination in healthy volunteers. Br J Clin Pharmacol (1986) 0.80
Biomechanical performance of orthopedic gloves. J Biomed Mater Res (1999) 0.80
Topical application of synthetic pyrethroids to cattle as a source of persistent environmental contamination. J Environ Sci Health B (1997) 0.79
Electrophysiological and biochemical effects of single and multiple doses of the organophosphate diazinon in the mouse. Toxicol Appl Pharmacol (2000) 0.79
Butobarbitone metabolism in man: identification of 3'-ketobutobarbitone. J Pharm Pharmacol (1974) 0.79
The effect of age and frailty upon blood esterase activities and their response to dietary supplementation. Br J Clin Pharmacol (1993) 0.79
Fate of fluazifop butyl in rat and human skin in vitro. Arch Toxicol (1993) 0.78
Cytogenetic response without changes in peripheral cholinesterase enzymes following exposure to a sheep dip containing diazinon in vivo and in vitro. Mutat Res (2000) 0.78
Division synchrony and the dynamics of microbial populations: a size-specific model. Theor Popul Biol (1984) 0.78
7-Ethoxyresorufin deethylase (EROD) in human liver--the effect of alcoholic liver disease. Eur J Clin Pharmacol (1987) 0.78
Maternal and neonatal elimination of amobarbital after treatment of the mother with barbiturates during late pregnancy. Clin Pharmacol Ther (1976) 0.78
Animal pharmacology of guanfacine. Am J Cardiol (1986) 0.78
The percutaneous absorption and skin distribution of lindane in man. I. In vivo studies. Hum Exp Toxicol (1997) 0.78
Phenazone (antipyrine) metabolism and distribution in young and elderly adults. Clin Exp Pharmacol Physiol (1978) 0.78